vs

Side-by-side financial comparison of Acadian Asset Management Inc. (AAMI) and CASTLE BIOSCIENCES INC (CSTL). Click either name above to swap in a different company.

Acadian Asset Management Inc. is the larger business by last-quarter revenue ($172.2M vs $83.7M, roughly 2.1× CASTLE BIOSCIENCES INC). Acadian Asset Management Inc. runs the higher net margin — 20.2% vs -17.4%, a 37.5% gap on every dollar of revenue. On growth, Acadian Asset Management Inc. posted the faster year-over-year revenue change (2.6% vs -4.9%). Over the past eight quarters, Acadian Asset Management Inc.'s revenue compounded faster (27.6% CAGR vs -1.9%).

United Asset Management was an American holding company headquartered in Boston, Massachusetts.

Castle Biosciences Inc. is a commercial-stage diagnostic firm that develops and markets proprietary, clinically actionable tests for dermatological conditions such as melanoma and other skin cancers, plus rare diseases. It operates mainly in the U.S. healthcare market, focusing on segments with high unmet need for more accurate diagnostics to guide treatment choices.

AAMI vs CSTL — Head-to-Head

Bigger by revenue
AAMI
AAMI
2.1× larger
AAMI
$172.2M
$83.7M
CSTL
Growing faster (revenue YoY)
AAMI
AAMI
+7.5% gap
AAMI
2.6%
-4.9%
CSTL
Higher net margin
AAMI
AAMI
37.5% more per $
AAMI
20.2%
-17.4%
CSTL
Faster 2-yr revenue CAGR
AAMI
AAMI
Annualised
AAMI
27.6%
-1.9%
CSTL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AAMI
AAMI
CSTL
CSTL
Revenue
$172.2M
$83.7M
Net Profit
$34.7M
$-14.5M
Gross Margin
Operating Margin
33.3%
Net Margin
20.2%
-17.4%
Revenue YoY
2.6%
-4.9%
Net Profit YoY
-18.4%
43.8%
EPS (diluted)
$0.97
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AAMI
AAMI
CSTL
CSTL
Q1 26
$83.7M
Q4 25
$172.2M
$87.0M
Q3 25
$144.2M
$83.0M
Q2 25
$127.4M
$86.2M
Q1 25
$119.9M
$88.0M
Q4 24
$167.8M
$86.3M
Q3 24
$123.1M
$85.8M
Q2 24
$109.0M
$87.0M
Net Profit
AAMI
AAMI
CSTL
CSTL
Q1 26
$-14.5M
Q4 25
$34.7M
Q3 25
$15.1M
$-501.0K
Q2 25
$10.1M
$4.5M
Q1 25
$20.1M
$-25.8M
Q4 24
$42.5M
Q3 24
$16.9M
$2.3M
Q2 24
$11.0M
$8.9M
Gross Margin
AAMI
AAMI
CSTL
CSTL
Q1 26
Q4 25
79.0%
Q3 25
77.5%
Q2 25
79.5%
Q1 25
81.4%
Q4 24
81.3%
Q3 24
81.8%
Q2 24
83.3%
Operating Margin
AAMI
AAMI
CSTL
CSTL
Q1 26
Q4 25
33.3%
-4.4%
Q3 25
18.4%
-8.2%
Q2 25
12.7%
-4.9%
Q1 25
26.6%
-31.7%
Q4 24
38.7%
4.7%
Q3 24
21.9%
5.9%
Q2 24
18.9%
5.8%
Net Margin
AAMI
AAMI
CSTL
CSTL
Q1 26
-17.4%
Q4 25
20.2%
Q3 25
10.5%
-0.6%
Q2 25
7.9%
5.2%
Q1 25
16.8%
-29.4%
Q4 24
25.3%
Q3 24
13.7%
2.6%
Q2 24
10.1%
10.3%
EPS (diluted)
AAMI
AAMI
CSTL
CSTL
Q1 26
$-0.49
Q4 25
$0.97
$-0.06
Q3 25
$0.42
$-0.02
Q2 25
$0.28
$0.15
Q1 25
$0.54
$-0.90
Q4 24
$1.11
$0.32
Q3 24
$0.45
$0.08
Q2 24
$0.29
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AAMI
AAMI
CSTL
CSTL
Cash + ST InvestmentsLiquidity on hand
$63.8M
Total DebtLower is stronger
$200.0M
$10.1M
Stockholders' EquityBook value
$461.4M
Total Assets
$677.0M
$547.8M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AAMI
AAMI
CSTL
CSTL
Q1 26
$63.8M
Q4 25
$299.5M
Q3 25
$287.5M
Q2 25
$275.9M
Q1 25
$275.2M
Q4 24
$293.1M
Q3 24
$95.0M
Q2 24
$85.6M
Total Debt
AAMI
AAMI
CSTL
CSTL
Q1 26
$10.1M
Q4 25
$200.0M
$10.1M
Q3 25
$10.0M
Q2 25
$10.0M
Q1 25
$10.0M
Q4 24
$275.0M
$10.0M
Q3 24
$10.0M
Q2 24
$10.0M
Stockholders' Equity
AAMI
AAMI
CSTL
CSTL
Q1 26
$461.4M
Q4 25
$470.9M
Q3 25
$467.0M
Q2 25
$455.4M
Q1 25
$440.3M
Q4 24
$455.8M
Q3 24
$441.1M
Q2 24
$423.9M
Total Assets
AAMI
AAMI
CSTL
CSTL
Q1 26
$547.8M
Q4 25
$677.0M
$578.6M
Q3 25
$751.4M
$562.8M
Q2 25
$672.3M
$544.7M
Q1 25
$677.3M
$501.7M
Q4 24
$703.2M
$531.2M
Q3 24
$555.2M
$514.6M
Q2 24
$533.1M
$487.3M
Debt / Equity
AAMI
AAMI
CSTL
CSTL
Q1 26
0.02×
Q4 25
0.02×
Q3 25
0.02×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.02×
Q2 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AAMI
AAMI
CSTL
CSTL
Operating Cash FlowLast quarter
$-2.4M
$-22.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.07×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AAMI
AAMI
CSTL
CSTL
Q1 26
$-22.1M
Q4 25
$-2.4M
$26.9M
Q3 25
$-23.9M
$22.6M
Q2 25
$61.6M
$20.8M
Q1 25
$-48.8M
$-6.0M
Q4 24
$55.8M
$24.4M
Q3 24
$69.6M
$23.3M
Q2 24
$45.7M
$24.0M
Free Cash Flow
AAMI
AAMI
CSTL
CSTL
Q1 26
Q4 25
$19.7M
Q3 25
$7.8M
Q2 25
$11.6M
Q1 25
$-10.8M
Q4 24
$16.8M
Q3 24
$17.0M
Q2 24
$18.8M
FCF Margin
AAMI
AAMI
CSTL
CSTL
Q1 26
Q4 25
22.7%
Q3 25
9.4%
Q2 25
13.4%
Q1 25
-12.2%
Q4 24
19.5%
Q3 24
19.8%
Q2 24
21.6%
Capex Intensity
AAMI
AAMI
CSTL
CSTL
Q1 26
Q4 25
8.3%
Q3 25
17.9%
Q2 25
10.7%
Q1 25
5.4%
Q4 24
8.8%
Q3 24
7.4%
Q2 24
6.0%
Cash Conversion
AAMI
AAMI
CSTL
CSTL
Q1 26
Q4 25
-0.07×
Q3 25
-1.58×
Q2 25
6.10×
4.60×
Q1 25
-2.43×
Q4 24
1.31×
Q3 24
4.12×
10.29×
Q2 24
4.15×
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons